Erratum to: Considerations of Human Health Risk Assessment in Chemical Accident: Suggestions from a Toxicogenomic Approach

[1]  Jay Kapellusch,et al.  The Revised Strain Index: an improved upper extremity exposure assessment model , 2017, Ergonomics.

[2]  Manuel J. Rodríguez,et al.  Barriers to the use of toxicogenomics data in human health risk assessment: A survey of Canadian risk assessors , 2017, Regulatory toxicology and pharmacology : RTP.

[3]  G. Lemasters,et al.  Exposure assessment models for elemental components of particulate matter in an urban environment: A comparison of regression and random forest approaches. , 2017, Atmospheric environment.

[4]  Y. Maruthi,et al.  Trace Elemental Characterization of Chalk Dust and Their Associated Health Risk Assessment , 2017, Biological Trace Element Research.

[5]  Thomas C. Wiegers,et al.  The Comparative Toxicogenomics Database: update 2017 , 2016, Nucleic Acids Res..

[6]  Sichuang Tang,et al.  The application of FLUENT in simulating outcomes from chlorine leakage accidents in a typical chemical factory , 2016, Toxicology and industrial health.

[7]  B. P. D. Batvari,et al.  Heavy metals accumulation in crab and shrimps from Pulicat lake, north Chennai coastal region, southeast coast of India , 2016, Toxicology and industrial health.

[8]  Keigo Saito,et al.  Biomarkers for the early diagnosis of hepatocellular carcinoma. , 2015, World journal of gastroenterology.

[9]  R. Verhaak,et al.  Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm , 2015, Scientific Reports.

[10]  M. Barton Predictive biomarkers may help individualize treatment for patients with follicular lymphoma , 2013, CA: a cancer journal for clinicians.

[11]  J. V. Van Eyk,et al.  Secreted proteins as a fundamental source for biomarker discovery , 2012, Proteomics.

[12]  R. Judson,et al.  Estimating toxicity-related biological pathway altering doses for high-throughput chemical risk assessment. , 2011, Chemical research in toxicology.

[13]  A. Hubbard,et al.  Toxicogenomic profiling of chemically exposed humans in risk assessment. , 2010, Mutation research.

[14]  K. Strimbu,et al.  What are biomarkers? , 2010, Current opinion in HIV and AIDS.

[15]  Xiaosi Su,et al.  Transport and fate modeling of nitrobenzene in groundwater after the Songhua River pollution accident. , 2010, Journal of environmental management.

[16]  Jonathan I Levy,et al.  Science and Decisions: Advancing Risk Assessment , 2010, Risk analysis : an official publication of the Society for Risk Analysis.

[17]  Marylyn D. Ritchie,et al.  PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations , 2010, Bioinform..

[18]  Jun Hee Lee,et al.  Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression , 2010, Cell.

[19]  Anton Yuryev,et al.  Ariadne's ChemEffect and Pathway Studio knowledge base , 2009, Expert opinion on drug discovery.

[20]  Michael Dourson,et al.  Resources for global risk assessment: the International Toxicity Estimates for Risk (ITER) and Risk Information Exchange (RiskIE) databases. , 2008, Toxicology and applied pharmacology.

[21]  R. Stenner Kees Van Leeuwen, Theo Vermeire (Eds.): Risk assessment of chemicals—an introduction , 2008 .

[22]  E. Wagner,et al.  Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease , 2008, Arthritis research & therapy.

[23]  El-Nabi Kamel,et al.  Effect of toluene exposure on the antioxidant status and apoptotic pathway in organs of the rat , 2008, British journal of biomedical science.

[24]  Pierre R. Bushel,et al.  CEBS—Chemical Effects in Biological Systems: a public data repository integrating study design and toxicity data with microarray and proteomics data , 2007, Nucleic Acids Res..

[25]  G. Sauter,et al.  Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer , 2007, Nature Genetics.

[26]  Jon A Arnot,et al.  Screening level risk assessment model for chemical fate and effects in the environment. , 2006, Environmental science & technology.

[27]  Darrell R Boverhof,et al.  Toxicogenomics in risk assessment: applications and needs. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  M. Tuzcu,et al.  Effects of thinner exposure on the expression pattern of neural cell adhesion molecules, level of lipid peroxidation in the brain and cognitive function in rats. , 2005, European journal of pharmacology.

[29]  G Heinemeyer,et al.  European union system for the evaluation of substances: the second version. , 2005, Chemosphere.

[30]  G. Alink,et al.  The Definition of Hormesis and its Implications for In Vitro to In Vivo Extrapolation and Risk Assessment , 2005, Critical reviews in toxicology.

[31]  Francois Pognan,et al.  Genomics, proteomics and metabonomics in toxicology: hopefully not 'fashionomics'. , 2004, Pharmacogenomics.

[32]  J. Woodcock,et al.  Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective , 2004, Nature Reviews Drug Discovery.

[33]  Antonio Di Guardo,et al.  Regional differences in chemical fate model outcome. , 2004, Chemosphere.

[34]  William Pennie,et al.  Toxicogenomics in risk assessment: an overview of an HESI collaborative research program. , 2004, Environmental health perspectives.

[35]  A. Svobodová,et al.  Natural phenolics in the prevention of UV-induced skin damage. A review. , 2003, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.

[36]  David Baltimore,et al.  NF-κB functions in synaptic signaling and behavior , 2003, Nature Neuroscience.

[37]  Melvin E Andersen,et al.  Toxicokinetic modeling and its applications in chemical risk assessment. , 2003, Toxicology letters.

[38]  Emanuel F. Petricoin,et al.  Medical applications of microarray technologies: a regulatory science perspective , 2002, Nature Genetics.

[39]  C. Travis,et al.  The Genomic Revolution: What Does It Mean for Risk Assessment? , 2001, Risk analysis : an official publication of the Society for Risk Analysis.

[40]  R Tardif,et al.  A PBPK modeling-based approach to account for interactions in the health risk assessment of chemical mixtures. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.

[41]  C. Duggan,et al.  The use of genomics technology to investigate gene expression changes in cultured human liver cells. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[42]  T. Kepler,et al.  Morphologic analysis correlates with gene expression changes in cultured F344 rat mesothelial cells. , 2000, Toxicology and applied pharmacology.

[43]  M. Camps,et al.  Dual specificity phosphatases: a gene family for control of MAP kinase function , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  J. Féher,et al.  IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease , 1999, Immunogenetics.

[45]  I. Purchase,et al.  Principles of risk assessment , 1998 .

[46]  Y. Ryu,et al.  Cerebral perfusion impairment in a patient with toluene abuse. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[47]  Herbert H. P. Fang,et al.  Toxicity of phenol towards anaerobic biogranules , 1997 .

[48]  A. Gelman,et al.  Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions , 1996 .

[49]  J. D. Geddes,et al.  Microbial ecology, toxicology and chemical fate of methyl isothiocyanate in riparian soils from the upper Sacramento river , 1996 .

[50]  H. Hirai,et al.  Toluene inhibits synaptic transmission without causing gross morphological disturbances , 1994, Brain Research.

[51]  T. E. McKone,et al.  CalTOX, a multimedia total exposure model for hazardous-waste sites; Part 1, Executive summary , 1993 .

[52]  J. Fentem,et al.  The Use of Basal Cytotoxicity and Target Organ Toxicity Tests in Hazard Identification and Risk Assessment , 1992 .

[53]  P. Stewart,et al.  Mortality among Industrial Workers Exposed to Phenol , 1991, Epidemiology.

[54]  L. Reichardt,et al.  Studies on the expression of the beta nerve growth factor (NGF) gene in the central nervous system: level and regional distribution of NGF mRNA suggest that NGF functions as a trophic factor for several distinct populations of neurons. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Waters,et al.  Toxicogenomics in Predictive Carcinogenicity , 2016 .

[56]  Tian Xin,et al.  Simulation of Diffusion Trend of Unexpected Gas Leak Accident based on Google Earth , 2012 .

[57]  Lei Da,et al.  Analysis of Chemical Disasters Caused by Release of Hydrogen Sulfide-bearing Natural Gas , 2011 .

[58]  Dongil Shin,et al.  Development of chemical accident database: Considerations, accident trend analysis and suggestions , 2011, Korean Journal of Chemical Engineering.

[59]  M. Kanter,et al.  The Oxidative and Morphological Effects of High Concentration Chronic Toluene Exposure on Rat Sciatic Nerves , 2004, Neurochemical Research.

[60]  M. Lyons,et al.  Interleukin (IL)-8 (CXCL8) induces cytokine expression and superoxide formation by guinea pig neutrophils infected with Mycobacterium tuberculosis. , 2004, Tuberculosis.

[61]  J. Groten,et al.  Toxicological evaluation and risk assessment of chemical mixtures. , 1998, Critical reviews in toxicology.

[62]  Philippe Bourdeau,et al.  Methods for assessing and reducing injury from chemical accidents , 1989 .

[63]  J. O’Donoghue Neurotoxicity of industrial and commercial chemicals , 1985 .